Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00243659
Status:
COMPLETED
Last Update Posted:
2011-06-03
First Post:
2005-10-20
Brief Title:
Study Evaluating B-Domain Deleted Recombinant Factor VIII BDDrFVIII ReFacto AF in Patients With Hemophilia A Undergoing Elective Major Surgery
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization Data
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Class:
INDUSTRY
Study ID:
3082B2-311
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Wyeth Registry Contact Clinical Trial Registry Specialist
Old Organization:
Wyeth